ClinicalTrials.gov Noncompliance By Industry Remains An FDA Concern

Despite “concerted” communications efforts by FDA, only 47% of clinical trials sponsored by industry are listed on registry website. Oncology Division Director Pazdur tells a House hearing that industry reluctance confuses the agency, which acknowledges “limited” enforcement capabilities.